Search details
1.
GADD45A: With or without you.
Med Res Rev
; 44(4): 1375-1403, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38264852
2.
SIRT1 regulates hepatic vldlr levels.
Cell Commun Signal
; 22(1): 297, 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38807218
3.
Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer's Disease Hallmarks.
Int J Mol Sci
; 25(5)2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-38473843
4.
CHOP upregulation and dysregulation of the mature form of the SNAT2 amino acid transporter in the placentas from small for gestational age newborns.
Cell Commun Signal
; 21(1): 326, 2023 11 13.
Article
in English
| MEDLINE | ID: mdl-37957724
5.
A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
Pharmacol Res
; 187: 106578, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36435271
6.
Design and Synthesis of AMPK Activators and GDF15 Inducers.
Molecules
; 28(14)2023 Jul 17.
Article
in English
| MEDLINE | ID: mdl-37513338
7.
Endoplasmic reticulum stress downregulates PGC-1α in skeletal muscle through ATF4 and an mTOR-mediated reduction of CRTC2.
Cell Commun Signal
; 20(1): 53, 2022 04 15.
Article
in English
| MEDLINE | ID: mdl-35428325
8.
The PPARß/δ-AMPK Connection in the Treatment of Insulin Resistance.
Int J Mol Sci
; 22(16)2021 Aug 09.
Article
in English
| MEDLINE | ID: mdl-34445261
9.
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.
Cell Commun Signal
; 18(1): 147, 2020 09 10.
Article
in English
| MEDLINE | ID: mdl-32912335
10.
PPARß/δ: A Key Therapeutic Target in Metabolic Disorders.
Int J Mol Sci
; 19(3)2018 Mar 20.
Article
in English
| MEDLINE | ID: mdl-29558390
11.
VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.
Diabetologia
; 60(11): 2262-2273, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28835988
12.
PPARß/δ and lipid metabolism in the heart.
Biochim Biophys Acta
; 1861(10): 1569-78, 2016 10.
Article
in English
| MEDLINE | ID: mdl-26825692
13.
PPARß/δ ameliorates fructose-induced insulin resistance in adipocytes by preventing Nrf2 activation.
Biochim Biophys Acta
; 1852(5): 1049-58, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25728706
14.
PPARß/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
Diabetologia
; 57(10): 2126-35, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25063273
15.
Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARß/δ-null mice.
Biochim Biophys Acta
; 1832(8): 1241-8, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23507144
16.
Increased hepatic gluconeogenesis and type 2 diabetes mellitus.
Trends Endocrinol Metab
; 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38816269
17.
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-ß1/SMAD3 pathway.
Metabolism
; 152: 155772, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38176644
18.
TNF-α inhibits PPARß/δ activity and SIRT1 expression through NF-κB in human adipocytes.
Biochim Biophys Acta
; 1821(9): 1177-85, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22683888
19.
Striking a gut-liver balance for the antidiabetic effects of metformin.
Trends Pharmacol Sci
; 44(7): 457-473, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37188578
20.
Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress.
Biomed Pharmacother
; 168: 115667, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37826940